Literature DB >> 31971151

Putting Guidance into Practice: Interpretation of the Oral Cholera Vaccine Recommendations for U.S. Travelers.

Erin E Conners1, Kristina M Angelo2, Allison T Walker2.   

Abstract

The American Committee on Immunization Practices recommends the use of the oral cholera vaccine (OCV) in international travelers aged 18-64 years who visit areas of active cholera transmission. CDC Travelers' Health Branch currently tracks areas of active cholera transmission and posts this information on their country-specific destination web pages at https://wwwnc.cdc.gov/travel/destinations/list. Lessons learned from a webinar conducted among health care providers have led to improvements in how CDC shares information on the OCV. Here, we summarize the major considerations for providers offering the OCV to U.S. travelers and indicate where they can find more information.

Mesh:

Substances:

Year:  2020        PMID: 31971151      PMCID: PMC7056432          DOI: 10.4269/ajtmh.19-0511

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  2 in total

Review 1.  PaxVax CVD 103-HgR single-dose live oral cholera vaccine.

Authors:  Myron M Levine; Wilbur H Chen; James B Kaper; Michael Lock; Lisa Danzig; Marc Gurwith
Journal:  Expert Rev Vaccines       Date:  2017-03       Impact factor: 5.217

2.  Recommendations of the Advisory Committee on Immunization Practices for Use of Cholera Vaccine.

Authors:  Karen K Wong; Erin Burdette; Barbara E Mahon; Eric D Mintz; Edward T Ryan; Arthur L Reingold
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-05-12       Impact factor: 17.586

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.